Bioqual, Inc. (OTCMKTS:BIOQ - Get Free Report)'s stock price traded down 6.2% on Thursday . The company traded as low as $57.50 and last traded at $57.50. 500 shares traded hands during trading, an increase of 150% from the average session volume of 200 shares. The stock had previously closed at $61.30.
Bioqual Stock Performance
The firm has a market cap of $51.41 million, a P/E ratio of -18.37 and a beta of -0.33. The stock has a 50 day simple moving average of $60.33 and a 200-day simple moving average of $64.74.
Bioqual (OTCMKTS:BIOQ - Get Free Report) last posted its quarterly earnings data on Tuesday, January 21st. The company reported ($1.36) earnings per share (EPS) for the quarter. Bioqual had a negative net margin of 5.54% and a negative return on equity of 7.50%.
Bioqual Company Profile
(
Get Free Report)
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Articles
Before you consider Bioqual, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioqual wasn't on the list.
While Bioqual currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
